These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 10581050)

  • 21. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
    Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
    Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chimeric EWS-FLI1 transcript in a Ewing cell line with a complex t(11;22;14) translocation.
    Bonin G; Scamps C; Turc-Carel C; Lipinski M
    Cancer Res; 1993 Aug; 53(16):3655-7. PubMed ID: 8339272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EWS/FLI-1 antagonists induce growth inhibition of Ewing tumor cells in vitro.
    Kovar H; Aryee DN; Jug G; Henöckl C; Schemper M; Delattre O; Thomas G; Gadner H
    Cell Growth Differ; 1996 Apr; 7(4):429-37. PubMed ID: 9052984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties.
    Bertolotti A; Bell B; Tora L
    Oncogene; 1999 Dec; 18(56):8000-10. PubMed ID: 10637511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenovirus 5 early region 1A does not induce expression of the ewing sarcoma fusion product EWS-FLI1 in breast and ovarian cancer cell lines.
    Meric F; Liao Y; Lee WP; Pollock RE; Hung MC
    Clin Cancer Res; 2000 Oct; 6(10):3832-6. PubMed ID: 11051226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of Fli-1 in normal cell function and malignant transformation.
    Truong AH; Ben-David Y
    Oncogene; 2000 Dec; 19(55):6482-9. PubMed ID: 11175364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The NFATc2 gene is involved in a novel cloned translocation in a Ewing sarcoma variant that couples its function in immunology to oncology.
    Szuhai K; Ijszenga M; de Jong D; Karseladze A; Tanke HJ; Hogendoorn PC
    Clin Cancer Res; 2009 Apr; 15(7):2259-68. PubMed ID: 19318479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EWS-Fli1 antisense oligodeoxynucleotide inhibits proliferation of human Ewing's sarcoma and primitive neuroectodermal tumor cells.
    Tanaka K; Iwakuma T; Harimaya K; Sato H; Iwamoto Y
    J Clin Invest; 1997 Jan; 99(2):239-47. PubMed ID: 9005992
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Induction of tenascin-C by tumor-specific EWS-ETS fusion genes.
    Watanabe G; Nishimori H; Irifune H; Sasaki Y; Ishida S; Zembutsu H; Tanaka T; Kawaguchi S; Wada T; Hata J; Kusakabe M; Yoshida K; Nakamura Y; Tokino T
    Genes Chromosomes Cancer; 2003 Mar; 36(3):224-32. PubMed ID: 12557222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting of EWS/FLI-1 by RNA interference attenuates the tumor phenotype of Ewing's sarcoma cells in vitro.
    Chansky HA; Barahmand-Pour F; Mei Q; Kahn-Farooqi W; Zielinska-Kwiatkowska A; Blackburn M; Chansky K; Conrad EU; Bruckner JD; Greenlee TK; Yang L
    J Orthop Res; 2004 Jul; 22(4):910-7. PubMed ID: 15183454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of various exon combinations of the ews/fli1 translocation: an optimized RT-PCR method for paraffin embedded tissue -- a report by the CWS-study group.
    Stegmaier S; Leuschner I; Aakcha-Rudel E; Münch P; Kazanowska B; Bekassy A; Treuner J; Koscielniak E
    Klin Padiatr; 2004; 216(6):315-22. PubMed ID: 15565546
    [TBL] [Abstract][Full Text] [Related]  

  • 32. STAT3 is activated in a subset of the Ewing sarcoma family of tumours.
    Lai R; Navid F; Rodriguez-Galindo C; Liu T; Fuller CE; Ganti R; Dien J; Dalton J; Billups C; Khoury JD
    J Pathol; 2006 Apr; 208(5):624-32. PubMed ID: 16463269
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transforming activity of EWS/FLI is not strictly dependent upon DNA-binding activity.
    Jaishankar S; Zhang J; Roussel MF; Baker SJ
    Oncogene; 1999 Sep; 18(40):5592-7. PubMed ID: 10523836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EWS-FLI1 fusion protein up-regulates critical genes in neural crest development and is responsible for the observed phenotype of Ewing's family of tumors.
    Hu-Lieskovan S; Zhang J; Wu L; Shimada H; Schofield DE; Triche TJ
    Cancer Res; 2005 Jun; 65(11):4633-44. PubMed ID: 15930281
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction.
    Mangham DC; Williams A; McMullan DJ; McClure J; Sumathi VP; Grimer RJ; Davies AM
    Histopathology; 2006 Mar; 48(4):363-76. PubMed ID: 16487358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential transactivation by alternative EWS-FLI1 fusion proteins correlates with clinical heterogeneity in Ewing's sarcoma.
    Lin PP; Brody RI; Hamelin AC; Bradner JE; Healey JH; Ladanyi M
    Cancer Res; 1999 Apr; 59(7):1428-32. PubMed ID: 10197607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cryptic exons as a source of increased diversity of Ewing tumor-associated EWS-FLI1 chimeric products.
    Kovar H; Jugovic D; Melot T; Zoubek A; Lenoir G; Fink FM; Philip I; Turc-Carel C; Thomas G; Zucman-Rossi J
    Genomics; 1999 Sep; 60(3):371-4. PubMed ID: 10493837
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preferential down-regulation of phospholipase C-beta in Ewing's sarcoma cells transfected with antisense EWS-Fli-1.
    Dohjima T; Ohno T; Banno Y; Nozawa Y; Wen-yi Y; Shimizu K
    Br J Cancer; 2000 Jan; 82(1):16-9. PubMed ID: 10638960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E1A sensitizes HER2/neu-overexpressing Ewing's sarcoma cells to topoisomerase II-targeting anticancer drugs.
    Zhou Z; Jia SF; Hung MC; Kleinerman ES
    Cancer Res; 2001 Apr; 61(8):3394-8. PubMed ID: 11309298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel markers of subclinical disease for Ewing family tumors from gene expression profiling.
    Cheung IY; Feng Y; Danis K; Shukla N; Meyers P; Ladanyi M; Cheung NK
    Clin Cancer Res; 2007 Dec; 13(23):6978-83. PubMed ID: 18056173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.